| |
 |
|
Class Information
Number: 514/654
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain > The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only
Description: Subject matter wherein the chain consists of two or more carbons which are unsubstituted or substituted by acyclic hydrocarbon groups.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7619005 |
Methods for treating cognitive impairment in humans with Multiple Sclerosis |
Nov. 17, 2009 |
| 7589127 |
Aminoalkylphenols, methods of using and making the same |
Sep. 15, 2009 |
| 7560491 |
Z-stilbenes derivatives and the pharmaceutical composition thereof |
Jul. 14, 2009 |
| 7547723 |
Comprehensive pharmacologic therapy for treatment of a dysfunction |
Jun. 16, 2009 |
| 7456222 |
Anti tubercular drug: compositions and methods |
Nov. 25, 2008 |
| 7273888 |
Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis |
Sep. 25, 2007 |
| 7256204 |
Amine compounds, their production and use |
Aug. 14, 2007 |
| 7244769 |
Methods for treating an impairment in memory consolidation |
Jul. 17, 2007 |
| 7226951 |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
Jun. 5, 2007 |
| 7223748 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
May. 29, 2007 |
| RE39593 |
1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects |
Apr. 24, 2007 |
| 7176243 |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis |
Feb. 13, 2007 |
| 7157488 |
N-(2-Arylethyl) benzylamines as antagonists of the 5-HT.sub.6 receptor |
Jan. 2, 2007 |
| 7147864 |
Methods for preventing photodamaged skin by administering selegiline or desmethylselegiline |
Dec. 12, 2006 |
| 7148233 |
Treatment of cardiovascular and related pathologies |
Dec. 12, 2006 |
| 7144892 |
Treatment of cardiovascular and related pathologies |
Dec. 5, 2006 |
| 7132430 |
Treatment of cardiovascular and related pathologies |
Nov. 7, 2006 |
| 7125889 |
Treating of cardiovascular and related pathologies |
Oct. 24, 2006 |
| 7052833 |
Absorptive hypercalciuria locus on human chromosome 1 |
May. 30, 2006 |
| 7053122 |
Therapeutic use of aryl amino acid derivatives |
May. 30, 2006 |
| 7026343 |
Pharmacologic inhibition of Myc function |
Apr. 11, 2006 |
| 7001925 |
Compounds and method for enhancing the efficacy of anti-cancer drugs |
Feb. 21, 2006 |
| 6974568 |
Treatment for cough |
Dec. 13, 2005 |
| 6960588 |
Tryptase inhibitors |
Nov. 1, 2005 |
| 6946441 |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
Sep. 20, 2005 |
| 6939895 |
Calcium receptor-active compounds |
Sep. 6, 2005 |
| 6930122 |
Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
Aug. 16, 2005 |
| 6924313 |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
Aug. 2, 2005 |
| 6897241 |
Preparation of topical regional compositions for the relief of pain |
May. 24, 2005 |
| 6884794 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
Apr. 26, 2005 |
| 6881748 |
Drug targeting |
Apr. 19, 2005 |
| 6828351 |
Methods and compositions for regulating memory consolidation |
Dec. 7, 2004 |
| 6828318 |
2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
Dec. 7, 2004 |
| 6818672 |
Treating endometriosis or infertility, or improving fertility |
Nov. 16, 2004 |
| 6787570 |
Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Sep. 7, 2004 |
| 6765023 |
Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jul. 20, 2004 |
| 6765022 |
Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
Jul. 20, 2004 |
| 6759053 |
S(+) Desmethylselegiline and its use to treat ADHD |
Jul. 6, 2004 |
| 6750255 |
Calcium receptor-active compounds |
Jun. 15, 2004 |
| 6743824 |
Method for preventing and treating peripheral neuropathy by administering selegiline |
Jun. 1, 2004 |
| 6730706 |
Treatments using venlafaxine |
May. 4, 2004 |
| 6723753 |
Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6723752 |
(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6710088 |
Inorganic ion receptor-active compounds |
Mar. 23, 2004 |
| 6710089 |
Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Mar. 23, 2004 |
| 6709664 |
Methods for treating photodamaged skin by administering selegiline or desmethylselegiline |
Mar. 23, 2004 |
| 6706686 |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
Mar. 16, 2004 |
| 6703424 |
Dispersible compositions containing L-DOPA ethyl ester |
Mar. 9, 2004 |
| 6699495 |
Methods for treating multiple sclerosis employing desmethylselegiline |
Mar. 2, 2004 |
| 6693133 |
Methods of cardioprotection using dichloroacetate in combination with an inotrope |
Feb. 17, 2004 |
|
|
|
